
@ShahidNShah
GlobalData, a data and analytics company, said on Tuesday that with the new technological innovations like Virtual Reality (VR) and Augmented Reality (AR), healthcare companies are discovering more ways to use these advancements for complex diseases. Recently, XRHealth published a study that shows the potential of using virtual reality (VR) technologies in upper limb dysfunction in multiple sclerosis patients. “The COVID-19 pandemic triggered a shift to remote working that has boosted the adoption of VR by enterprises for training, collaboration, data visualization, and customer experience. Furthermore, more companies start to study ways to use VR in physiotherapy and treating various neurological disorders. As a result, the use of VR is expanding in the healthcare industry along with other new technologies, such as machine learning and artificial intelligence,” Kamilla Kan, Medical Analyst at GlobalData, said in a statement on Tuesday.
Continue reading at financialexpress.com
Barriers to API adoption for digital health companies include a lack of realistic clinical testing data and EHR data fragmentation. Application programming interface (API) adoption is common in many …
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm